Microbot Medical Inc. (FRA:CY9D)

Market Cap	140.16M
Revenue (ttm)	n/a
Net Income (ttm)	-11.14M
Shares Out	n/a
EPS (ttm)	-0.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,100
Average Volume	315
Open	2.264
Previous Close	1.971
Day's Range	2.264 - 2.300
52-Week Range	0.881 - 4.268
Beta	n/a
RSI	63.55
Earnings Date	Nov 20, 2025

About Microbot Medical

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology i...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2010
• Employees: 20
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CY9D

Financial Performance

Financial numbers in USD